1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Pulmonary Inflammation: new trials by email Literature Review of Pulmonary Inflammation trials Research Report on Pulmonary Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Inhaled SNSP113, Inhaled Placebo - Lung Diseases, Pulmonary Disease | Phase 1 | Terminated | Synspira, Inc. | 32 | 2017-09-28 | 2018-05-25 |
| Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 CTX-4430, Mannitol, Placebo - Pulmonary Inflammation | Phase 1 | Completed | Celtaxsys, Inc. | 96 | 2012-12-01 | 2013-09-10 |
Pneumonia (2) · Burkholderia Infections (1) · Cystic Fibrosis (1) · Infections (1) · Lung Diseases (1) · Mycobacterium Infections, Nontuberculous (1) · Respiratory Tract Diseases (1)
Respiratory Tract Infections (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Genetic Diseases, Inborn (1) · Gram-Negative Bacterial Infections (1) · Gram-Positive Bacterial Infections (1) · Infant, Newborn, Diseases (1) · Infections (1) · Lung Diseases (1) · Mycobacterium Infections (1) · Pancreatic Diseases (1) · Respiratory Tract Diseases (1)
Mannitol (1) · acebilustat (1)
Celtaxsys, Inc. (1) · Synspira, Inc. (1)
Australia (1) · United Kingdom (1)
Janakan Krishnarajah, MB, BS FRACP (1) · Maria Theresa Basco, MD, MPH (1)